Suppliers / Minh

Minh

Updated 9 July 2026

Minh is an API manufacturer. It appears in 189 regulatory filings across 1 regulator, without an active US DMF or CEP on file. Customs aggregates show $52K of exports covering 33 molecules to 1 destination in 2022.

0
active US DMFs
0
valid CEPs
0
registered plants
189
filings across 1 regulators

What they file, and where

Molecule Regulators Docs
Amoxicilin DAV (Vietnam) 4
Cefadroxil DAV (Vietnam) 3
Cefaclor DAV (Vietnam) 2
Flavoxate DAV (Vietnam) 2
Ivermectin DAV (Vietnam) 2
Lornoxicam DAV (Vietnam) 2
Acid Clavulanic DAV (Vietnam) 1
Acyclovir DAV (Vietnam) 1
Ambroxol DAV (Vietnam) 1
Attapulgite DAV (Vietnam) 1
Show all 27 molecules on file
Cefradine DAV (Vietnam) 1
Cefuroxime DAV (Vietnam) 1
Cloramphenicol DAV (Vietnam) 1
Diphenhydramine DAV (Vietnam) 1
Doripenem DAV (Vietnam) 1
Ebastine DAV (Vietnam) 1
Flurbiprofen DAV (Vietnam) 1
Ketoconazole DAV (Vietnam) 1
Ketorolac DAV (Vietnam) 1
Lysine DAV (Vietnam) 1
Mesalazine DAV (Vietnam) 1
Miconazole DAV (Vietnam) 1
Naftidrofuryl DAV (Vietnam) 1
Naphazoline DAV (Vietnam) 1
Pyrantel DAV (Vietnam) 1
Tobramycin DAV (Vietnam) 1
Tranexamic Acid DAV (Vietnam) 1

Also appears on these molecule pages

Filings and GMP by regulator

Regulator Filings GMP certificates
DAV (Vietnam) 189 None

Scale

Year Revenue Exports Destinations
2022 Not reported $52K 1

Export figures are customs aggregates. We do not publish the identity of any buyer.

Comparing suppliers?

Choose your molecules and target markets. Minh comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
Customs aggregates
Export values, molecule and destination counts